MONUDIN Trademark

Trademark Overview


On Friday, June 13, 2003, a trademark application was filed for MONUDIN with the United States Patent and Trademark Office. The USPTO has given the MONUDIN trademark a serial number of 78262176. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 11, 2013. This trademark is owned by Oxford BioMedica plc. The MONUDIN trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology

Gene therapy and prophylaxis products, namely gene transfer, regulation, modulation and delivery products for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders

Instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization

Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy

General Information


Serial Number78262176
Word MarkMONUDIN
Filing DateFriday, June 13, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 11, 2013
Registration Number3214651
Registration DateTuesday, March 6, 2007
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 5, 2006

Trademark Statements


Goods and ServicesChemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
Goods and ServicesGene therapy and prophylaxis products, namely gene transfer, regulation, modulation and delivery products for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders
Goods and ServicesInstruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization
Goods and ServicesScientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 11, 2013
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 11, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 11, 2013
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 11, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxford BioMedica plc
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB

Party NameOxford BioMedica plc
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB

Party NameOxford BioMedica plc
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB

Trademark Events


Event DateEvent Description
Friday, October 11, 2013CANCELLED SEC. 8 (6-YR)
Tuesday, March 6, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, January 23, 20071(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, January 23, 2007NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 26, 2006PAPER RECEIVED
Tuesday, November 28, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 5, 2006PUBLISHED FOR OPPOSITION
Wednesday, August 16, 2006NOTICE OF PUBLICATION
Tuesday, July 11, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 7, 2006ASSIGNED TO LIE
Monday, July 3, 2006EXAMINERS AMENDMENT MAILED
Monday, July 3, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 3, 2006EXAMINER'S AMENDMENT ENTERED
Monday, July 3, 2006EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 7, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 31, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 31, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 6, 2005NON-FINAL ACTION MAILED
Tuesday, December 6, 2005NON-FINAL ACTION WRITTEN
Thursday, November 10, 2005DATA MODIFICATION COMPLETED
Monday, October 17, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, October 3, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 3, 2005PAPER RECEIVED
Thursday, March 31, 2005LETTER OF SUSPENSION MAILED
Wednesday, March 30, 2005SUSPENSION LETTER WRITTEN
Thursday, March 24, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 9, 2005EXAMINER'S AMENDMENT ENTERED
Tuesday, March 8, 2005EXAMINERS AMENDMENT E-MAILED
Tuesday, March 8, 2005EXAMINERS AMENDMENT -WRITTEN
Monday, February 14, 2005AMENDMENT FROM APPLICANT ENTERED
Friday, January 28, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 28, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 4, 2004NON-FINAL ACTION MAILED
Monday, June 21, 2004AMENDMENT FROM APPLICANT ENTERED
Monday, June 21, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 21, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 22, 2003NON-FINAL ACTION E-MAILED
Saturday, December 20, 2003ASSIGNED TO EXAMINER